National Institute on Aging; Notice of Closed Meetings, 51310-51311 [E8-20186]
Download as PDF
51310
Federal Register / Vol. 73, No. 170 / Tuesday, September 2, 2008 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Neurological Sciences
Training Initial Review Group, NST–1
Subcommittee.
Date: September 8–9, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The M Street Renaissance Hotel,
1143 New Hampshire Avenue, NW.,
Washington, DC 20037.
Contact Person: Raul A. Saavedra, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, NSC; 6001 Executive
Blvd., Ste. 3208, Bethesda, MD 20892–9529,
301–496–9223, saavedrr@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: August 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–20183 Filed 8–29–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
erowe on PROD1PC64 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, T35
Short-Term Institutional Research Training
Grant.
Date: September 24, 2008.
Time: 12 p.m. to 1:30 p.m.
VerDate Aug<31>2005
14:40 Aug 29, 2008
Jkt 214001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Christopher Moore, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Health/NIDCD, 6120 Executive Blvd, Rm.
400C, Bethesda, MD 20892–7180, 301–402–
3587, moorechristopher@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, P30
Research Core Center.
Date: September 30, 2008.
Time: 1:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Christine A. Livingston,
PhD, Scientific Review Administrator,
Division of Extramural Activities, National
Institutes of Health/ NIDCD, 6120 Executive
Blvd.—MSC 7180, Bethesda, MD 20892,
(301) 496–8683, livingsc@mail.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, R03
Hearing and Balance.
Date: October 7, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sheo Singh, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
Executive Plaza South, Room 400C, 6120
Executive Blvd., Bethesda, MD 20892, 301–
496–8683, singhs@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, R03
Voice, Speech, & Language.
Date: October 9, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Christopher Moore, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Health/NIDCD, 6120 Executive Blvd, Rm.
400C, Bethesda, MD 20892–7180. 301–402–
3587, moorechristopher@nidcd.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Disorders, National Institutes of Health,
HHS).
Dated: August 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–20184 Filed 8–29–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, AD
Coordinating Center.
Date: September 26, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20814 (Telephone
Conference Call).
Contact Person: Alicja L. Markowska, PhD,
DSC, National Institute on Aging, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20814, 301–496–9666,
markowsa@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Alzheimer
Pathogenesis I.
Date: October 2, 2008.
Time: 3 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Bldg., 7201 Wisconsin Avenue, Rm
2C212, Bethesda, MD 20814 (Telephone
Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Administrator, Scientific
Review Office, National Institute on Aging,
Gateway Bldg., 2C212, 7201 Wisconsin
Avenue, Bethesda, MD 20814, 301–402–
7701, nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Mitochondria
in Neurodegenerative Disease I.
E:\FR\FM\02SEN1.SGM
02SEN1
Federal Register / Vol. 73, No. 170 / Tuesday, September 2, 2008 / Notices
Date: October 27, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Bldg., 7201 Wisconsin Avenue, Rm
2C212, Bethesda, MD 20814 (Telephone
Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Administrator, Scientific
Review Office, National Institute on Aging,
Gateway Bldg., 2C212, 7201 Wisconsin
Avenue, Bethesda, MD 20814, 301–402–
7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–20186 Filed 8–29–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
erowe on PROD1PC64 with NOTICES
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
VerDate Aug<31>2005
14:40 Aug 29, 2008
Jkt 214001
of automated collection techniques or
other forms of information technology.
Proposed Project: GPRA Client
Outcomes for the Substance Abuse and
Mental Health Services Administration
(SAMHSA)—(OMB No. 0930–0208)—
Revision
SAMHSA’s Center for Substance
Abuse Treatment (CSAT) is responsible
for collecting data from discretionary
services grants and contracts where
client outcomes are to be assessed at
three points (intake, discharge, and
post-intake). SAMHSA’s CSAT-funded
projects are required to submit these
data as a contingency of their award.
The analysis of the data also will help
determine whether the goal of reducing
health and social costs of drug use to the
public is being achieved.
The primary purpose of this data
collection activity is to meet the
reporting requirements of the
Government Performance and Results
Act (GPRA) by allowing SAMHSA to
quantify the effects and
accomplishments of SAMHSA’s CSAT
programs.
CSAT requests approval to increase
the number of questions in the
instrument due to the agency’s need for
additional information from its
programs to satisfy reporting needs. The
additional information needed is the
following:
• Co-Occurring Disorders Screening—
Over the years, CSAT has focused
attention on co-occurring disorders and
has established programs designed
specifically for persons with both cooccurring disorders and substance abuse
problems. CSAT wants to make sure
that all clients are screened regardless of
the types of program they enter in order
to get the treatment they need. CSAT
has not had a formal way of assessing
whether all programs screen clients for
co-occurring disorders and
consequently, these disorders
potentially go untreated. CSAT will be
able to monitor if clients are screened
and for those who screen positive,
monitor their outcomes and activities
per the NOMS.
• Veteran Status—Collection of these
data will allow CSAT to identify the
number of veterans served and the types
of services they received. Identifying a
client’s veteran’s status allows CSAT
and the grantees to monitor these clients
and explore whether special services or
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
51311
programs are needed to treat them for
substance abuse and other related
issues. Identification of veteran status
will also allow coordination between
SAMHSA and other Federal agencies in
order to provide a full range of services
to veterans. CSAT will also be able to
monitor their outcomes and activities
per the NOMS.
• HIV Test Status—SAMHSA is
committed to addressing the twin
epidemics of HIV and substance abuse;
the agency has received funding to
augment the HIV testing program and
hopes to reduce the number of new
cases. The goal is for at least 80 percent
of the clients to be tested for HIV. The
test results give clients and programs an
important piece of information needed
for their substance abuse treatment
plans. With the testing information,
CSAT will monitor the numbers of
treatment clients who have been tested.
In addition, we will add a response
option to an existing item:
• Housing for College Students—
Housing stability is one of the NOMs
and should be calculated as accurately
as possible, particularly for programs
that target college students such as
Campus SBIRT. There currently is no
way to distinguish the housing status of
students living on campus from those
housed elsewhere. This additional
information can be captured by adding
a new response option for the existing
housing question.
CSAT requests approval to add a grant
program to this data collection:
• CSAT will add the Access to
Recovery (ATR) grant program to this
data collection for the CSAT
Government Performance and Results
Act (GPRA) Client Outcome Measures
for Discretionary Programs instrument.
The Voucher Information Form (OMB
0930–0266, Expiration Date 5/31/11)
and Voucher Transaction Form (OMB
0930–0266, Expiration Date 5/31/11)
will remain under separate data
collections. ATR requires the integration
of evidence-based practices and a
systematic federal scrutiny of outcomes
through GPRA. The GPRA focuses on
results or outcomes in evaluating the
effectiveness of Federal activities and on
measuring progress toward achieving
national goals and objectives.
The estimated annual response
burden for this data collection is
provided in the table below:
E:\FR\FM\02SEN1.SGM
02SEN1
Agencies
[Federal Register Volume 73, Number 170 (Tuesday, September 2, 2008)]
[Notices]
[Pages 51310-51311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-20186]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel, AD Coordinating Center.
Date: September 26, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Gateway, 7201 Wisconsin
Avenue, Suite 2C212, Bethesda, MD 20814 (Telephone Conference Call).
Contact Person: Alicja L. Markowska, PhD, DSC, National
Institute on Aging, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD
20814, 301-496-9666, markowsa@nia.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel, Alzheimer Pathogenesis I.
Date: October 2, 2008.
Time: 3 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Bldg., 7201
Wisconsin Avenue, Rm 2C212, Bethesda, MD 20814 (Telephone Conference
Call).
Contact Person: Bita Nakhai, PhD, Scientific Review
Administrator, Scientific Review Office, National Institute on
Aging, Gateway Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD
20814, 301-402-7701, nakhaib@nia.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel, Mitochondria in Neurodegenerative Disease I.
[[Page 51311]]
Date: October 27, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Bldg., 7201
Wisconsin Avenue, Rm 2C212, Bethesda, MD 20814 (Telephone Conference
Call).
Contact Person: Bita Nakhai, PhD, Scientific Review
Administrator, Scientific Review Office, National Institute on
Aging, Gateway Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD
20814, 301-402-7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: August 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-20186 Filed 8-29-08; 8:45 am]
BILLING CODE 4140-01-P